凱杰生物QGEN
紐約證券 · USD
49.94
+0.60
(+1.22%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
凱杰生物QGEN
49.94
+0.60
(+1.22%)
財務數據
損益表
- 4.98
- 4.85
- 4.95
- 4.76
- 5.09
- 4.59
- 4.96
- 5.02
- 5.21
- 4.83
- -0.33
- -2.53
- 1.95
- -3.83
- 6.99
- -9.89
- 8.18
- 1.11
- 3.85
- -7.24
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 483,456 | 521,202 | 501,869 | 496,347 | 458,796 | 509,162 | 475,894 | 494,857 | 485,398 | 497,984 |
營業成本 | 174,775 | 187,912 | 193,562 | 461,583 | 167,807 | 193,062 | 177,934 | 182,705 | 177,922 | 180,460 |
營業毛利 | 308,681 | 333,290 | 308,307 | 34,764 | 290,989 | 316,100 | 297,960 | 312,152 | 307,476 | 317,524 |
營業費用 | 183,518 | 192,126 | 187,460 | 195,121 | 192,744 | 194,610 | 190,758 | 198,118 | 204,955 | 204,899 |
研發費用 | 43,783 | 48,605 | 44,453 | 49,103 | 51,333 | 45,966 | 47,934 | 49,893 | 54,718 | 44,719 |
推銷及管理費用 | 137,942 | 141,712 | 140,656 | 143,304 | 138,689 | 145,952 | 140,111 | 145,523 | 147,580 | 154,211 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 125,163 | 141,164 | 120,847 | -160,357 | 98,245 | 121,490 | 107,202 | 114,034 | 102,521 | 112,625 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 7,294 | 11,143 | 11,484 | 10,922 | 10,292 | 12,441 | 13,018 | 13,497 | 14,454 | 14,875 |
稅前純益 | 119,549 | 125,852 | 116,456 | -223,451 | 102,290 | 118,876 | 99,830 | 102,316 | 108,787 | 105,837 |
所得稅 | 28,791 | 37,530 | 18,400 | -39,991 | 21,617 | 21,212 | 22,012 | 21,530 | 23,752 | 16,993 |
稅後純益 | 90,758 | 88,322 | 98,056 | -183,460 | 80,673 | 97,664 | 77,818 | 80,786 | 85,035 | 88,844 |
基本每股稅後盈餘(元) | 0.42 | 0.40 | 0.44 | -0.83 | 0.35 | 0.43 | 0.33 | 0.35 | 0.37 | 0.39 |
稀釋每股稅後盈餘(元) | 0.41 | 0.39 | 0.44 | -0.83 | 0.35 | 0.42 | 0.33 | 0.35 | 0.36 | 0.39 |
基本平均股數(千股) | 218377.00 | 222290.00 | 222314.00 | 221989.00 | 230230.00 | 228202.00 | 235317.00 | 228182.00 | 228035.00 | 227716.00 |
稀釋平均股數(千股) | 220189.00 | 224245.00 | 224035.00 | 221989.00 | 233045.00 | 230745.00 | 237745.00 | 230517.00 | 237734.00 | 230357.00 |
還原基本每股稅後盈餘(元) | 0.42 | 0.41 | 0.45 | -0.85 | 0.36 | 0.45 | 0.35 | 0.38 | 0.40 | 0.41 |
還原稀釋每股稅後盈餘(元) | 0.41 | 0.40 | 0.45 | -0.85 | 0.36 | 0.45 | 0.35 | 0.37 | 0.38 | 0.41 |
還原基本平均股數(千股) | 218,377 | 216,115 | 216,138 | 215,822 | 223,835 | 215,207 | 221,917 | 215,188 | 215,049 | 214,749 |
還原稀釋平均股數(千股) | 220,189 | 218,015 | 217,811 | 215,822 | 226,572 | 217,605 | 224,207 | 217,390 | 224,196 | 217,239 |
EBITDA(千元) | 170,751 | 182,547 | 177,933 | -159,136 | 166,912 | 182,887 | 163,417 | 166,949 | 175,302 | 175,384 |